Related Experiment Video
Updated: Jul 17, 2026

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Chronic aortic regurgitation: the effect of aortic valve replacement on left ventricular volume, mass and function
Insights
Aortic valve replacement (AVR) successfully reduces left ventricular (LV) volume and mass in patients with chronic aortic regurgitation (AR). The radius-to-wall thickness ratio predicts outcomes, aiding in managing LV remodeling post-surgery.
Area of Science:
- Cardiology
- Cardiac Surgery
- Echocardiography
Background:
- Chronic aortic regurgitation (AR) leads to left ventricular (LV) dilation and dysfunction.
- Aortic valve replacement (AVR) is the standard treatment for severe AR.
- Understanding the impact of AVR on LV remodeling is crucial for patient management.
Purpose of the Study:
- To assess the serial changes in LV volume, mass, and function after AVR in patients with chronic AR.
- To identify echocardiographic parameters predicting successful surgical outcomes.
- To evaluate the prognostic value of the LV end-diastolic radius-to-wall thickness (R/Th) ratio.
Main Methods:
- Serial echocardiographic studies were performed in 19 patients before and after AVR.
- LV dimensions, wall thickness, and derived muscle mass (cross-sectional area) were analyzed.
- The R/Th ratio was calculated and correlated with clinical outcomes.
Main Results:
- Successful AVR significantly reduced LV end-diastolic dimension and normalized LV mass within six months.
- Systolic function showed a trend toward improvement by late postop.
- A preop R/Th ratio >= 4 differentiated patients with suboptimal LV dimension reduction post-AVR.
Conclusions:
- Successful AVR normalizes LV volume and decreases LV mass in chronic AR.
- The preop R/Th ratio is a valuable prognostic indicator for LV remodeling after AVR.
- This ratio may offer insights independent of fractional shortening in select AR patients.
Abstract:
Serial echocardiographic left ventricular (LV) studies were performed in 19 patients before (preop) and after (postop) aortic valve replacement (AVR) for chronic aortic regurgitation (AR); the effect of AVR on LV volume, mass and function was determined from the echocardiographic data. In the 12 patients who were considered to have successful surgical results, the average LV end-diastolic dimension fell from a preop value of 6.9 +/- 0.2 cm to 5.5 +/- 0.2 cm (P less than 0.01) at the time of the early postop study (seven to 10 days). Muscle cross-sectional area (CSA) derived from dimension and wall thickness data was used as an index of LV muscle mass (preop CSA = 26 +/- 1.3 cm2); CSA was unchanged at the early postop study, but subsequently fell to near normal within six months after AVR (20 +/- 1 cm2, P less than 0.01). There was a trend toward improvement in systolic performance by the late postop studies (12+ months). In two out of three patients with postop paravalvular AR, LV dimension increased after an initial fall. Four patients without paravalvular AR failed to show a significant reduction in LV dimension in the postop studies. In this group the preop studies showed a tendency toward a large end-diastolic dimension and decreased fractional shortening, but the single preop parameter which differentiated these four from the successfully treated group was an end-diastolic radius-to-wall thickness (R/Th) ratio greater than or equal to 4. Thus, successful AVR for chronic AR results in the normalization of LV volume and a decrease in LV muscle mass to near normal. The R/Th ratio has important prognostic value which appears to be independent of fractional shortening in some patients with chronic AR.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Heart Failure II: Pathophysiology

